Global View: ACC, Power Grid, Abbott India and Nykaa could give 10-30% return in 12 months
Indian market is likely to consolidate on Thursday, tracking muted global cues, but there will be stock-specific action in which global brokerage came out with their reports on business development, or earnings outlook.
Indian market is likely to consolidate on Thursday, tracking muted global cues, but there will be stock-specific action in which global brokerage came out with their reports on business development, or earnings outlook.
We have collated a list of recommendations from various global brokerage firms according to a Zee Business TV report:
ACC: Buy| Target Rs 2710
CLSA maintained a buy rating on ACC post December quarter results with a target price of Rs 2710 that translates into an upside of over 17 per cent from Rs 2310 recorded on 9 February.
See Zee Business Live TV Streaming Below:
4QCY21 Ebitda of Rs5.6bn (down 21% YoY, 22% QoQ) missed estimates on higher costs. Volumes also fell by about 4% YoY to 7.4mt.
Blended realisations remain flat on a QoQ basis and Ebitda/t fell 18% YoY (-31% QoQ) to Rs749 & was weaker than estimates.
Power Grid: Target Rs 250
CLSA maintained buy rating on Power Grid post December quarter results with a target price of Rs 250 that translates into an upside of over 19 per cent from Rs 210 recorded on 9 February.
The company declared 2nd interim dividend. Rajasthan green corridor commissioning & HVDC projects will be key drivers. The global investment bank see earnings growth of 29% over FY 21-24, said the note.
Abbott India: Buy| Target Rs 21,830
CLSA maintained a buy rating on Abbott India post December quarter results with a target price of Rs 21,830 which translates into an upside of over 30 per cent from Rs 16,750 recorded on 9 February.
The Q3 profit growth was largely in-line with the estimate. The company is positioned for double-digit growth in revenue and earnings, said the note.
Macro concerns from rising yields on growth stocks make us cut our target PE, the note added.
Nykaa: Overweight| Target Rs 2040
Morgan Stanley maintained an overweight rating on Nykaa post December quarter results with a target price of Rs 2040 that translates into an upside of over 10 per cent from Rs 1850 recorded on 9 February.
The 3Q earnings were ahead of estimates on top line and margins. The company continues to focus on driving growth and profitability.
The gross margins improved to 46%, up 450bps on a YoY basis. However, EBITDA margins saw a compression of 700bps YoY to 6.3% due to higher marketing expenses, said the note.
(Disclaimer: The views/suggestions/advice expressed here in this article are solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
EPFO Pension Schemes: Early pension, retirement pension, nominee pension and 4 other pension schemes that every private sector employee should know
Power of Compounding: How soon will monthly SIP of Rs 6,000, Rs 8,000, and Rs 10,000 reach Rs 5 crore corpus target?
SIP+SWP: Rs 10,000 monthly SIP for 20 years, Rs 25 lakh lump sum investment, then Rs 2.15 lakh monthly income for 25 years; see expert calculations
SIP vs PPF: How much corpus you can build in 15 years by investing Rs 1.5 lakh per year? Understand through calculations
SBI Guaranteed Return Scheme: Know how much maturity amount you will get on Rs 2 lakh, 2.5 lakh, 3 lakh, 3.5 lakh and Rs 4 lakh investments under Amrit Vrishti FD scheme
09:43 AM IST